Literature DB >> 10367629

Cystic neoplasms of the pancreas--cystadenomas and cystadenocarcinomas.

W Meyer1, J Köhler, C Gebhardt.   

Abstract

INTRODUCTION: Among the rare cystic pancreatic tumors, serous and mucinous cystadenoma and mucinous cystadenocarcinoma are most often diagnosed. CASE: We report on a total of 21 patients with cystic neoplasms who underwent surgery, 11 of whom had mucinous cystadenocarcinoma. Of the 10 remaining patients, serous and mucinous cystadenoma were diagnosed in two groups of five. A common feature of all cystic neoplasms is slow growth, leading to clinical symptoms at an advanced stage, with tumors frequently becoming enormous.
RESULTS: In approximately half of the cases, diagnosis was possible by means of ultrasound, computed tomography and, in three instances, by preoperative percutaneous aspiration. Differential diagnosis of pseudocysts proved to be most difficult.
CONCLUSION: Given the low operative risk, resection should always be performed in instances where findings cannot be clearly identified. Moreover, compared with ductal pancreatic carcinomas, the prognosis of a cystadenocarcinoma after early resection is extremely favorable, so that postponing resection might reduce the patient's prospects of being cured.

Entities:  

Mesh:

Year:  1999        PMID: 10367629     DOI: 10.1007/s004230050172

Source DB:  PubMed          Journal:  Langenbecks Arch Surg        ISSN: 1435-2443            Impact factor:   3.445


  7 in total

1.  Distal pancreatectomy: en-bloc splenectomy vs spleen-preserving pancreatectomy.

Authors:  Laureano Fernández-Cruz; David Orduña; Gleydson Cesar-Borges; Miguel Angel López-Boado
Journal:  HPB (Oxford)       Date:  2005       Impact factor: 3.647

2.  Outcomes of cystic lesions in the pancreas after extended follow-up.

Authors:  Sang Hyub Lee; Cheol Min Shin; Joo Kyung Park; Sang Myung Woo; Ji Won Yoo; Ji Kon Ryu; Yong Bum Yoon; Yong-Tae Kim
Journal:  Dig Dis Sci       Date:  2007-04-03       Impact factor: 3.199

3.  Differentiating benign from malignant pancreatic cysts on computed tomography.

Authors:  Rajesh Kumar Yadav; Xinhua Jiang; Jianyu Chen
Journal:  Eur J Radiol Open       Date:  2020-11-01

4.  Cystic pancreatic neoplasms: observe or operate.

Authors:  Kristine S Spinelli; Travis E Fromwiller; Roger A Daniel; James M Kiely; Attila Nakeeb; Richard A Komorowski; Stuart D Wilson; Henry A Pitt
Journal:  Ann Surg       Date:  2004-05       Impact factor: 12.969

5.  Risk of malignancy in resected cystic tumors of the pancreas < or =3 cm in size: is it safe to observe asymptomatic patients? A multi-institutional report.

Authors:  C J Lee; J Scheiman; M A Anderson; O J Hines; H A Reber; J Farrell; M L Kochman; P J Foley; J Drebin; Y S Oh; G Ginsberg; N Ahmad; N B Merchant; J Isbell; A A Parikh; J B Stokes; T Bauer; R B Adams; D M Simeone
Journal:  J Gastrointest Surg       Date:  2007-11-27       Impact factor: 3.452

6.  Cystic pancreatic neuroendocrine neoplasms with uncertain malignant potential: report of two cases.

Authors:  Roberto Ballarin; Michele Masetti; Luisa Losi; Fabrizio Di Benedetto; Stefano Di Sandro; Nicola De Ruvo; Roberto Montalti; Antonio Romano; Gian-Piero Guerrini; Maria-Grazia De Blasiis; Mario Spaggiari; Giorgio Enrico Gerunda
Journal:  Surg Today       Date:  2009-02-07       Impact factor: 2.549

7.  Pancreatic cystic neoplasms: predictors of malignant behavior and management.

Authors:  Ehab Atef; Ayman El Nakeeb; Ehab El Hanafy; Mohamed El Hemaly; Emad Hamdy; Ahmed El-Geidie
Journal:  Saudi J Gastroenterol       Date:  2013 Jan-Feb       Impact factor: 2.485

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.